fluprednisolone has been researched along with Episcleritis in 2 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data collected from all patients with anterior scleritis who used difluprednate as a single treatment agent from January 1, 2018, to January 1, 2020, including demographics, scleritis type, presence of nodules or necrosis, changes in scleritis activity, intraocular pressure (IOP), number of difluprednate drops used, best-corrected visual acuity (BCVA), and lens status." | 8.12 | Effectiveness of Difluprednate for the Treatment of Anterior Scleritis. ( Berkenstock, MK; Burkholder, BM; Liberman, P; Thorne, JE, 2022) |
| "Data collected from all patients with anterior scleritis who used difluprednate as a single treatment agent from January 1, 2018, to January 1, 2020, including demographics, scleritis type, presence of nodules or necrosis, changes in scleritis activity, intraocular pressure (IOP), number of difluprednate drops used, best-corrected visual acuity (BCVA), and lens status." | 4.12 | Effectiveness of Difluprednate for the Treatment of Anterior Scleritis. ( Berkenstock, MK; Burkholder, BM; Liberman, P; Thorne, JE, 2022) |
| "Difluprednate 0." | 1.36 | Intraocular pressure elevation from topical difluprednate use. ( Meehan, K; Sowka, J; Vollmer, L, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liberman, P | 1 |
| Burkholder, BM | 1 |
| Thorne, JE | 1 |
| Berkenstock, MK | 1 |
| Meehan, K | 1 |
| Vollmer, L | 1 |
| Sowka, J | 1 |
2 other studies available for fluprednisolone and Episcleritis
| Article | Year |
|---|---|
Effectiveness of Difluprednate for the Treatment of Anterior Scleritis.
Topics: Adolescent; Adult; Aged; Female; Fluprednisolone; Glucocorticoids; Humans; Intraocular Pressure; Mid | 2022 |
Intraocular pressure elevation from topical difluprednate use.
Topics: Administration, Topical; Black or African American; Emulsions; Female; Fluprednisolone; Glucocortico | 2010 |